Blood Clot Retrieval Devices Market Revenue & Forecast Analysis, 2026-2035

The blood clot retrieval devices market size was estimated to be worth USD 2,394.57 million in 2025. The market is expected to expand at a CAGR of 14.6% from USD 2,724.78 million in 2026 to USD 9,318.13 million by 2035. The market growth is driven by the increasing prevalence of acute ischemic stroke, rising adoption of mechanical thrombectomy procedures, and growing emphasis on timely restoration of blood flow to improve patient outcomes. Additionally, expanding availability of advanced neurovascular treatment facilities, increasing investments in stroke care infrastructure, and favourable clinical evidence supporting clot retrieval therapies are further driving global market expansion.

Published: July 16, 2026
100 Pages

Market Overview

A 2024 study published in the Journal of Stroke and Cerebrovascular Diseases highlighted the growing adoption of mechanical thrombectomy procedures for the treatment of acute ischemic stroke, demonstrating the increasing clinical utilization of blood clot retrieval devices across comprehensive stroke centers in the United States.

The blood clot retrieval devices market has experienced significant growth over the past decade, supported by advancements in neurointerventional techniques and the expanding use of endovascular stroke treatment protocols. Manufacturers are focusing on developing next-generation thrombectomy devices with improved clot engagement capabilities, enhanced navigability, and greater procedural effectiveness in complex vascular anatomies. For instance, a 2024 clinical study published in Stroke reported favorable outcomes associated with the use of advanced thrombectomy technologies in large vessel occlusion cases, reflecting the increasing integration of blood clot retrieval devices into modern stroke care pathways.

The anticipated growth of the blood clot retrieval devices market is fueled by ongoing clinical research supporting thrombectomy across broader patient populations, increasing establishment of dedicated stroke networks, and growing physician training in neurovascular interventions. Furthermore, industry participants are introducing innovative device designs aimed at improving first-pass recanalization rates and reducing procedure times to enhance treatment outcomes through 2035. For instance, in 2024, the American Heart Association highlighted the growing role of mechanical thrombectomy in evidence-based stroke management, reflecting the expanding utilization of blood clot retrieval devices in advanced neurovascular care.

Blood Clot Retrieval Devices Market Overview

Base Year Market Size (2025): USD 2,394.57 Million

CAGR: 14.6%

Forecast Year Market Size (2035): USD 9,318.13 Million

Leading Region: North America

Emerging Countries: China, India, Brazil, South Korea, Mexico

Major Players:

  • Medtronic plc

  • Stryker Corporation

  • Penumbra, Inc.

  • Johnson & Johnson (Cerenovus)

  • Terumo Corporation

  • Blood Clot Retrieval Devices Market Trends

The global blood clot retrieval devices market is undergoing significant transformation, driven by advancements in neurovascular intervention technologies and the increasing focus on improving stroke treatment outcomes.

  • The increasing adoption of aspiration-assisted thrombectomy and combined thrombectomy approaches is enhancing procedural success rates and expanding treatment options for complex clot removal cases.

  • Manufacturers are focusing on developing next-generation stent retrievers with improved flexibility, clot integration capabilities, and vessel navigation performance to optimize procedural efficiency.

  • The growing utilization of advanced imaging technologies for rapid stroke diagnosis and patient selection is supporting the timely deployment of blood clot retrieval devices in acute care settings.

  • Rising collaboration between healthcare providers and stroke care networks is improving treatment coordination and facilitating broader access to mechanical thrombectomy services.

  • Furthermore, the integration of artificial intelligence into stroke workflow management, increasing emphasis on first-pass recanalization performance, and ongoing product innovation focused on challenging vascular anatomies are reshaping the competitive landscape of the market.

Collectively, these advancements are expected to significantly propel market growth, accelerate innovation in thrombectomy technologies, and strengthen the global footprint of the blood clot retrieval devices industry in the coming years.

Blood Clot Retrieval Devices Market Analysis

By Product Type

Stent Retrievers dominate due to their proven clinical effectiveness and widespread adoption in mechanical thrombectomy procedures

Based on product type, the global blood clot retrieval devices market is segmented into stent retrievers, mechanical embolus removal devices, Penumbra blood clot retrieval devices, aspiration devices, and ultrasound-assisted devices. The stent retrievers segment led the market, accounting for the dominant market share in 2025.

By Application

Cerebral Arteries segment leads owing to the high prevalence of acute ischemic stroke and increasing utilization of neurovascular thrombectomy procedures

Based on application, the global blood clot retrieval devices market is segmented into cerebral arteries, coronary arteries, and peripheral arteries. The cerebral arteries segment led the market, holding the largest market share in 2025.

By End-use

Hospitals dominate due to the availability of advanced neurointerventional infrastructure and comprehensive stroke care services

Based on end-use, the global blood clot retrieval devices market is segmented into hospitals, ambulatory surgical centers, specialty centers, and others. The hospitals segment led the market, holding the dominant market share in 2025.

Regional Analysis

North America dominates due to advanced stroke care infrastructure

North America held the largest share of 44.17% in the global blood clot retrieval devices market in 2025.

Europe remains strong due to widespread thrombectomy adoption

Europe maintained the second most prominent position in the global blood clot retrieval devices market, supported by the growing utilization of mechanical thrombectomy procedures and well-established neurovascular treatment networks.

Key Companies Profiled

The competitive landscape of the global blood clot retrieval devices market is characterized by strong competition among leading neurovascular and medical device manufacturers. The key players in the industry, such as Medtronic plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson (Cerenovus), and Terumo Corporation, collectively hold a significant share of the market. Their leadership is supported by comprehensive thrombectomy product portfolios, continuous innovation in clot retrieval technologies, extensive clinical evidence, and strong distribution networks across major healthcare markets. Meanwhile, other companies are strengthening their market position through new product launches, strategic collaborations, and expansion of their neurovascular offerings.

The market is also witnessing increasing participation from emerging medical device companies developing advanced thrombectomy solutions to address evolving clinical requirements. Additionally, growing investments in next-generation stent retrievers, aspiration-based technologies, and devices designed to improve procedural efficiency are intensifying competition, encouraging manufacturers to enhance treatment effectiveness, expand clinical adoption, and strengthen their global market presence.

Blood Clot Retrieval Devices Market Companies:

Several prominent players driving innovation and growth in the blood clot retrieval devices industry are as follows:

  • Acandis GmbH

  • Anaconda Biomed, S.L.

  • Argon Medical Devices, Inc.

  • Balt Group

  • Imperative Care, Inc.

  • Inari Medical, Inc.

  • Johnson & Johnson MedTech (Cerenovus)

  • Kaneka Corporation

  • Medtronic plc

  • Merit Medical Systems, Inc.

  • MicroVention, Inc.

  • Penumbra, Inc.

  • Perflow Medical Ltd.

  • Phenox GmbH

  • Rapid Medical Ltd.

  • Route 92 Medical, Inc.

  • Stryker Corporation

  • Terumo Corporation

  • Vesalio, LLC

  • Wallaby Medical

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the Blood Clot Retrieval Devices Market by-

Product Type (Revenue in USD Million, 2021 - 2035)

  • Stent Retrievers

  • Mechanical Embolus Removal Devices

  • Penumbra Blood Clot Retrieval Devices

  • Aspiration Devices

  • Ultrasound Assisted Devices

Application (Revenue in USD Million, 2021 - 2035)

  • Cerebral Arteries

  • Coronary Arteries

  • Peripheral Arteries

End-use (Revenue in USD Million, 2021 - 2035)

  • Hospitals

  • Ambulatory Surgical Centers

  • Specialty Centers

  • Others

Regional (Revenue in USD Million, 2021 - 2035)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Switzerland

    • Netherlands

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn, Volume in Absolute Number)

4.1. Stent Retrievers

4.2. Mechanical Embolus Removal Devices

4.3. Penumbra Blood Clot Retrieval Devices

4.4. Aspiration Devices

4.5. Ultrasound Assisted Devices

5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

5.1. Cerebral Arteries

5.2. Coronary Arteries

5.3. Peripheral Arteries

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Ambulatory Surgical Centers

6.3. Specialty Centers

6.4. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2. U.K.

7.2.2.1. UK Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.2.2. Market Dynamics

7.2.2.3. Competitive Landscape

7.2.2.4. Regulatory Framework

7.2.2.5. Reimbursement Scenario

7.2.3. France

7.2.3.1. France Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. Italy

7.2.4.1. Italy Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Spain

7.2.5.1. Spain Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Sweden

7.2.6.1. Sweden Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Norway

7.2.7.1. Norway Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Denmark

7.2.8.1. Denmark Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Switzerland

7.2.9.1. Switzerland Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Netherlands

7.2.10.1. Netherlands Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.11. Rest of Europe

7.2.11.1. Rest of Europe Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Acandis GmbH

8.5.2. Anaconda Biomed, S.L.

8.5.3. Argon Medical Devices, Inc.

8.5.4. Balt Group

8.5.5. Imperative Care, Inc.

8.5.6. Inari Medical, Inc.

8.5.7. Johnson & Johnson MedTech (Cerenovus)

8.5.8. Kaneka Corporation

8.5.9. Medtronic plc

8.5.10. Merit Medical Systems, Inc.

8.5.11. MicroVention, Inc.

8.5.12. Penumbra, Inc.

8.5.13. Perflow Medical Ltd.

8.5.14. Phenox GmbH

8.5.15. Rapid Medical Ltd.

8.5.16. Route 92 Medical, Inc.

8.5.17. Stryker Corporation

8.5.18. Terumo Corporation

8.5.19. Vesalio, LLC

8.5.20. Wallaby Medical

8.6. Key Development Strategies

8.6.1. New Product Launches

8.6.2. Mergers and Acquisition

8.6.3. Partnerships and Collaborations

8.6.4. Expansion Plans

9. Analyst Perspective

10. Related Reports

Related Research

Radiofrequency Skin Rejuvenation Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Plaque Modification Devices Market Revenue & Forecast Analysis, 2026-2035

July 13, 2026View

Dental Splints Market Revenue & Forecast Analysis, 2026-2035

July 13, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.